Screener
Aspen Aerogels ASPN Deferred Revenue
Deferred Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Aspen Aerogels in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The source filing: Aspen Aerogels’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340275
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $20,958 | $13,243 |
| Accrued expenses | 19,129 | 12,952 |
| Deferred revenue | 25,534 | 1,259 |
| Finance obligation for sale and leaseback transactions | 4,875 | 4,443 |
| Operating lease liabilities | 2,947 | 3,245 |
| Finance lease liabilities | 1,860 | 1,768 |
| Long term debt - current portion | 23,346 | 25,115 |
Item 1. Financial Statements.
FAQ
- What is Aspen Aerogels's deferred revenue?
- Aspen Aerogels (ASPN) reported deferred revenue of $25.53M in Q2 2026.
- How has Aspen Aerogels's deferred revenue changed year-over-year?
- Aspen Aerogels's deferred revenue increased by 3992.0% year-over-year, from $624K to $25.53M.
- What is the long-term trend for Aspen Aerogels's deferred revenue?
- Over 5 years (2020 to 2025), Aspen Aerogels's deferred revenue has grown at a -9.2% compound annual growth rate (CAGR), from $2.04M to $1.26M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.
Ask your AI about Aspen Aerogels's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude